Pharmacy Times

AUGUST 13, 2025

The recent approval of brentuximab vedotin (BV, Adcetris; Seagen Inc) in combination with lenalidomide (Len, Revlimid; Bristol Myers Squibb) and a rituximab (R; BV-R2) product is a pivotal moment in cancer therapeutics and provides an alternative treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 19, 2025

Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. Jansen, PharmD Candidate , Mark A. 2,3 Hypertension remains a major public health challenge both in the United States and globally.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 2, 2025

These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. Nieto, BS, PharmD Candidate Amy C. The guidance is updated every 5 years, with the most recent update published in May 2025. Monitoring technology is valuable to assess glycemic control and enable timely interventions in T1D patients.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 14, 2025

PharmD Candidate , Kyla Ellis, PharmD Candidate +1 More Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options. These symptoms can be intermittent and worsen over time.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 1, 2025

Tafamidis, a selective transthyretin stabilizer, significantly reduces mortality and hospitalizations in ATTR-CM patients. SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 7, 2025

Pharmacists are essential in managing OIC, advising on treatment, monitoring effectiveness, and identifying contraindications and potential complications. Pharmacological support often starts with OTC agents, like water-holding laxatives (e.g., polyethylene glycol and lactulose) and stimulant laxatives (e.g., bisacodyl and senna).

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 16, 2025

Although the use of colony-stimulating factors (CSFs) is well-established in mitigating severe FN, existing literature suggests there is only an approximate 3% difference in FN rates between various CSF agents. Utilizing colony-stimulating factors (CSFs) decreases the incidence of severe FN.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 10, 2025

The convenience of once-daily dosing and a rapid IV bolus administration may offer workflow efficiencies in hospital or surgical settings, where minimizing polypharmacy and streamlining medication administration are important goals. 2 REFERENCES 1.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 21, 2025

Cardiovascular disease risks in HIV patients have evolved with ART, requiring preventive measures like statins and cardiovascular risk scores for effective management. Healthy aging in HIV patients involves addressing accelerated aging, multimorbidity, and geriatric syndromes, emphasizing functional ability and quality of life.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 8, 2025

Further research is needed on the clinical impact, treatment longevity, and cost implications of biosimilar use in pediatric IBD. 2 Tumor necrosis factor alpha inhibitors (anti-TNFs) have become both first- and second-line therapies for the treatment of pediatric patients with Crohn disease and ulcerative colitis.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 17, 2025

Understanding and addressing barriers to medication adherence are crucial for effective treatment of psychiatric disorders and improving patient outcomes. Long-acting injectable antipsychotics may improve adherence in homeless populations, but transportation and clinic visit logistics must be considered.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 7, 2025

The FDA's fast track designation highlights birelentinib's potential to meet unmet needs in CLL/SLL treatment. A cornerstone of treatment for these patients is BTK and BCL-2 inhibitors, but many patients progress or relapse on these therapies.

HIV Treatment and Prevention Agents

Pharmaceutical Technology

JULY 2, 2025

Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in the US, according to market analysts. Go deeper with GlobalData Reports LOA and PTSR Model - BRII-732 in Human Immunodeficiency Virus (HIV).

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 3, 2025

She emphasizes that treatment options are mostly supportive, making prevention through good hygiene and vaccination essential. Pharmacy Times: What are the key challenges in managing the high burden of RSV hospitalizations in older adults, and what broader strategies are needed to address them?

HIV Treatment and Prevention Agents

Pharmaceutical Technology

JUNE 11, 2025

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains unaffected. Gilead is considered the leading big pharma in HIV treatments. Shares in Nasdaq-listed Gilead opened 0.3%

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 15, 2025

Upon sensing dsRNA, the cell effectively halts protein synthesis, thereby preventing the virus from manufacturing the essential proteins required for its own reproduction. This innovative approach allowed for the high-throughput screening of many compounds, specifically 370,830, to discover potential therapeutic agents.

Compounding

The Thyroid Pharmacist

AUGUST 1, 2025

In fact, I skipped the breastfeeding class offered at my hospital to buy a second car with my hubby (we only had one car prior to starting a family). It is associated with better gastrointestinal adaptation, better infant sleep, less crying, and a reduced pain reaction (to routine hospital procedures). [3] I need to feed this baby!”

Health and Personal Care Stores

Hospital Pharmacy Europe

JUNE 19, 2025

Despite longstanding knowledge that TB is both preventable and curable, progress has stalled. He took aim at the diagnostic and preventive tools that have defined TB control for decades: the Bacillus Calmette-Guérin vaccine, Ziehl-Neelsen staining, microscopy and the tuberculin skin test. million deaths in 2023.

HIV Treatment and Prevention Agents

The Checkup by Singlecare

SEPTEMBER 26, 2023

Paxlovid can be a useful drug that can decrease the risk of hospitalization or death in high-risk individuals with COVID-19. It’s also recommended to discontinue atorvastatin and rosuvastatin during treatment with Paxlovid. In addition, other contraceptives should be continued until one menstrual cycle after stopping Paxlovid.

HIV Treatment and Prevention Agents

Pharmacy Friday Pearls

MARCH 4, 2022

18 years Administration Oral Oral Oral PK/PD MOA: Nirmatrelvir – inhibitor of the SARS-CoV-2 main protease Prevents viral replicationRitonavir is a CYP3A inhibitor included to increase nirmatrelvir plasma levelsRitonavir alone has NO activity against SARS-CoV-2 Time to peak: Nirmatrelvir: 3 hrs & Ritonavir: 3.98 Introduction.

HIV Treatment and Prevention Agents

Druggist

SEPTEMBER 2, 2021

Additionally, this drug is also known as anti-parasite successful against all viruses like HIV, Dengue, Influenza , and Zika virus. And stated its judicial use in preventing corona infection. To manage such a future crisis, healthcare experts might consider using Ivermectin tablets for its treatment and prevention.

HIV Treatment and Prevention Agents

The Thyroid Pharmacist

JULY 20, 2023

And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges. Viruses that have been associated with anemia include Epstein-Barr Virus , hepatitis A and C, human herpes virus 6 (HHV-6), cytomegalovirus, parvovirus B19, and HIV. [45] However, when they added 1.5

Health and Personal Care Stores

The Checkup by Singlecare

FEBRUARY 6, 2023

Pneumonia is often mild to moderate, requiring only outpatient treatment. Rarely can it be severe enough to require intensive care in a hospital? Risk factors of pneumonia are age older than 65, chronic obstructive pulmonary disorder ( COPD ), HIV infection , weakened immune system and smoking. Treatment depends on the cause.

HIV Treatment and Prevention Agents

IDStewardship

DECEMBER 11, 2024

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM BALANCE RCT : Among hospitalized patients with bloodstream infection, antibiotic treatment for 7 days was non-inferior to treatment for 14 days. RANDOMIZED CONTROLLED TRIALS 1. aureus bloodstream infection.

HIV Treatment and Prevention Agents